User talk:Bill Way

==Low dose naltroxene--

Please note Wikipedia policy WP:MEDRS which discourages the posting of multiple single studies in favour of systematic meta-analyses. The non-specialist reader should gather from an encyclopedic article the general state of knowledge on a topic, and small pilot studies do not merit substantial report here. Martinlc (talk) 23:02, 2 March 2013 (UTC)

Thanks for the head's up. I ask for a little leeway on this topic, as brief, concise citations of the studies conducted and under way provide the next-best alternative to an encyclopedic meta-analysis, which is not possible at this time. LDN deniers (e.g. Novella) say it's worthless, and posted the lengthy "pseudo-science" section, all based on Novella's claims, which are not based on clinical research at all. Proponents claim it works for everything, based on anecdotal reports which, while sometimes accurate, are unprovable. As TNI Biotech bought the patents for LDN in 2012 and committed to large-scale clinical trials with the objective of garnering FDA approval for LDN, this may change in the next few years.

I hesitated to include the Penn State MS trial, but believe that its dramatic outcome warrants its brief citation here. It is a study that could prove valuable, now, to people dealing with MS.

All that said, I am new to Wikipedia and do not want to violate your rules, so I do look to more experienced posters for guidance.

Bill Way (talk) 19:18, 3 March 2013 (UTC)